Effects of carbamazepine on the central nervous system of zebrafish at human therapeutic plasma levels
- PMID: 37701572
- PMCID: PMC10494213
- DOI: 10.1016/j.isci.2023.107688
Effects of carbamazepine on the central nervous system of zebrafish at human therapeutic plasma levels
Abstract
The fish plasma model (FPM) facilitated the environmental risk assessment of human drugs by using existing data on human therapeutic plasma concentrations (HTPCs) and predicted fish plasma concentrations (FPCs). However, studies on carbamazepine (CMZ) with both the mode of action (MOA) based biological effects at molecular level (such as neurotransmitter and gene level) and measured FPCs are lacking. Bioconcentration of CMZ in adult zebrafish demonstrated that the FPM underestimated the bioconcentration factors (BCFs) in plasma at environmental CMZ exposure concentrations (1-100 μg/L). CMZ significantly increased Glu and GABA, decreased ACh and AChE as well as inhibited the transcription levels of gabra1, grin1b, grin2b, gad1b, and abat when the actual FPCs were in the ranges of 1/1000 HTPC to HTPC. It is the first read-across study of CMZ integrating MOA-based biological effects at molecular level and FPCs. This study facilitates model performance against a range of different drug classes.
Keywords: Animal physiology; Biochemistry; Biological sciences; Physiology.
© 2023 The Authors.
Conflict of interest statement
The authors declare no competing interests.
Figures









References
-
- Barreto A., Santos J., Capitão A., Eusébio R., Pinheiro Damasceno É., Luísa Machado A., Rocha L.S., Calisto V., Amorim M.J.B., Maria V.L. Assessment of diphenhydramine toxicity-Is its mode of action conserved between human and zebrafish? Environ. Int. 2022;164 doi: 10.1016/j.envint.2022.107263. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous